These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11138927)

  • 1. Neuroserpin mutation S52R causes neuroserpin accumulation in neurons and is associated with progressive myoclonus epilepsy.
    Takao M; Benson MD; Murrell JR; Yazaki M; Piccardo P; Unverzagt FW; Davis RL; Holohan PD; Lawrence DA; Richardson R; Farlow MR; Ghetti B
    J Neuropathol Exp Neurol; 2000 Dec; 59(12):1070-86. PubMed ID: 11138927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and neuropathologic study of a French family with a mutation in the neuroserpin gene.
    Gourfinkel-An I; Duyckaerts C; Camuzat A; Meyrignac C; Sonderegger P; Baulac M; Brice A
    Neurology; 2007 Jul; 69(1):79-83. PubMed ID: 17606885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin OS-9 delivers mutant neuroserpin to endoplasmic reticulum associated degradation in familial encephalopathy with neuroserpin inclusion bodies.
    Schipanski A; Oberhauser F; Neumann M; Lange S; Szalay B; Krasemann S; van Leeuwen FW; Galliciotti G; Glatzel M
    Neurobiol Aging; 2014 Oct; 35(10):2394-403. PubMed ID: 24795221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of mutant neuroserpin precedes development of clinical symptoms in familial encephalopathy with neuroserpin inclusion bodies.
    Galliciotti G; Glatzel M; Kinter J; Kozlov SV; Cinelli P; Rülicke T; Sonderegger P
    Am J Pathol; 2007 Apr; 170(4):1305-13. PubMed ID: 17392169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encephalopathy with neuroserpin inclusion bodies presenting as progressive myoclonus epilepsy and associated with a novel mutation in the Proteinase Inhibitor 12 gene.
    Hagen MC; Murrell JR; Delisle MB; Andermann E; Andermann F; Guiot MC; Ghetti B
    Brain Pathol; 2011 Sep; 21(5):575-82. PubMed ID: 21435071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited Unfolded Protein Response and Inflammation in Neuroserpinopathy.
    López-González I; Pérez-Mediavilla A; Zamarbide M; Carmona M; Torrejón Escribano B; Glatzel M; Galliciotti G; Ferrer I
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):121-33. PubMed ID: 26733586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Japanese family with mutation in the proteinase inhibitor 12 L47P gene: A case report.
    Amano-Takeshige H; Oyama G; Kanai K; Miyagawa T; Mitsui J; Ugawa Y; Tsuji S; Hattori N
    J Neurol Sci; 2018 Jan; 384():126-128. PubMed ID: 29249370
    [No Abstract]   [Full Text] [Related]  

  • 8. The endoplasmic reticulum (ER)-associated degradation system regulates aggregation and degradation of mutant neuroserpin.
    Ying Z; Wang H; Fan H; Wang G
    J Biol Chem; 2011 Jun; 286(23):20835-44. PubMed ID: 21507957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterol metabolism regulates neuroserpin polymer degradation in the absence of the unfolded protein response in the dementia FENIB.
    Roussel BD; Newton TM; Malzer E; Simecek N; Haq I; Thomas SE; Burr ML; Lehner PJ; Crowther DC; Marciniak SJ; Lomas DA
    Hum Mol Genet; 2013 Nov; 22(22):4616-26. PubMed ID: 23814041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum.
    Miranda E; Römisch K; Lomas DA
    J Biol Chem; 2004 Jul; 279(27):28283-91. PubMed ID: 15090543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation-, aging-, and gene dosage-dependent accumulation of neuroserpin (G392E) in endoplasmic reticula and lysosomes of neurons in transgenic mice.
    Takasawa A; Kato I; Takasawa K; Ishii Y; Yoshida T; Shehata MH; Kawaguchi H; Mohafez OM; Sasahara M; Hiraga K
    J Biol Chem; 2008 Dec; 283(51):35606-13. PubMed ID: 18940798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive myoclonus epilepsy associated with neuroserpin inclusion bodies (neuroserpinosis).
    Roussel BD; Lomas DA; Crowther DC
    Epileptic Disord; 2016 Sep; 18(S2):103-110. PubMed ID: 27618835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G392E neuroserpin causing the dementia FENIB is secreted from cells but is not synaptotoxic.
    Ingwersen T; Linnenberg C; D'Acunto E; Temori S; Paolucci I; Wasilewski D; Mohammadi B; Kirchmair J; Glen RC; Miranda E; Glatzel M; Galliciotti G
    Sci Rep; 2021 Apr; 11(1):8766. PubMed ID: 33888787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between conformational mutations in neuroserpin and onset and severity of dementia.
    Davis RL; Shrimpton AE; Carrell RW; Lomas DA; Gerhard L; Baumann B; Lawrence DA; Yepes M; Kim TS; Ghetti B; Piccardo P; Takao M; Lacbawan F; Muenke M; Sifers RN; Bradshaw CB; Kent PF; Collins GH; Larocca D; Holohan PD
    Lancet; 2002 Jun; 359(9325):2242-7. PubMed ID: 12103288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial dementia caused by polymerization of mutant neuroserpin.
    Davis RL; Shrimpton AE; Holohan PD; Bradshaw C; Feiglin D; Collins GH; Sonderegger P; Kinter J; Becker LM; Lacbawan F; Krasnewich D; Muenke M; Lawrence DA; Yerby MS; Shaw CM; Gooptu B; Elliott PR; Finch JT; Carrell RW; Lomas DA
    Nature; 1999 Sep; 401(6751):376-9. PubMed ID: 10517635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroserpin polymers cause oxidative stress in a neuronal model of the dementia FENIB.
    Guadagno NA; Moriconi C; Licursi V; D'Acunto E; Nisi PS; Carucci N; De Jaco A; Cacci E; Negri R; Lupo G; Miranda E
    Neurobiol Dis; 2017 Jul; 103():32-44. PubMed ID: 28363799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB.
    Miranda E; MacLeod I; Davies MJ; Pérez J; Römisch K; Crowther DC; Lomas DA
    Hum Mol Genet; 2008 Jun; 17(11):1527-39. PubMed ID: 18267959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serpinopathies studying serpin polymerization in vivo.
    Irving JA; Ekeowa UI; Belorgey D; Haq I; Gooptu B; Miranda E; Pérez J; Roussel BD; Ordóñez A; Dalton LE; Thomas SE; Marciniak SJ; Parfrey H; Chilvers ER; Teckman JH; Alam S; Mahadeva R; Rashid ST; Vallier L; Lomas DA
    Methods Enzymol; 2011; 501():421-66. PubMed ID: 22078544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system.
    Yepes M; Lawrence DA
    Thromb Haemost; 2004 Mar; 91(3):457-64. PubMed ID: 14983220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroserpin: structure, function, physiology and pathology.
    D'Acunto E; Fra A; Visentin C; Manno M; Ricagno S; Galliciotti G; Miranda E
    Cell Mol Life Sci; 2021 Oct; 78(19-20):6409-6430. PubMed ID: 34405255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.